Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid in Metastatic Prostate Cancer
NCT00172016Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zoledronic acid in Metastatic Prostate Cancer (mPC), sponsored by Novartis. Started Jan 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on NCT00172016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00172016.